CANFOR PULP PRODUCTS INC (CFX.CA) Stock Fundamental Analysis
TSX:CFX - CA1375842079 - Common Stock
0.55 CAD
-0.01 (-1.79%)
Overall CFX gets a fundamental rating of 3 out of 10. We evaluated CFX against 12 industry peers in the Paper & Forest Products industry. CFX has a bad profitability rating. Also its financial health evaluation is rather negative. CFX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CFX was profitable.
In the past year CFX had a positive cash flow from operations.
In the past 5 years CFX always reported negative net income.
CFX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CFX's Return On Assets of -35.35% is on the low side compared to the rest of the industry. CFX is outperformed by 91.67% of its industry peers.
The Return On Equity of CFX (-87.05%) is worse than 91.67% of its industry peers.
With an excellent Return On Invested Capital value of 2.73%, CFX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -35.35% | ||
| ROE | -87.05% | ||
| ROIC | 2.73% |
ROA(3y)-20.14%
ROA(5y)-13.63%
ROE(3y)-46.33%
ROE(5y)-30.44%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 1.55%, CFX perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
Looking at the Gross Margin, with a value of 22.02%, CFX is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CFX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.55% | ||
| PM (TTM) | N/A | ||
| GM | 22.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.78%
GM growth 5Y-0.73%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CFX is destroying value.
Compared to 1 year ago, CFX has about the same amount of shares outstanding.
The number of shares outstanding for CFX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CFX has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.85, we must say that CFX is in the distress zone and has some risk of bankruptcy.
CFX has a worse Altman-Z score (0.85) than 83.33% of its industry peers.
The Debt to FCF ratio of CFX is 5.18, which is a neutral value as it means it would take CFX, 5.18 years of fcf income to pay off all of its debts.
CFX's Debt to FCF ratio of 5.18 is fine compared to the rest of the industry. CFX outperforms 66.67% of its industry peers.
CFX has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CFX (0.43) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 5.18 | ||
| Altman-Z | 0.85 |
ROIC/WACC0.28
WACC9.77%
2.3 Liquidity
CFX has a Current Ratio of 0.98. This is a bad value and indicates that CFX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, CFX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.23 indicates that CFX may have some problems paying its short term obligations.
CFX has a worse Quick ratio (0.23) than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.23 |
3. Growth
3.1 Past
CFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.37%, which is quite impressive.
CFX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.47%.
CFX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.00% yearly.
EPS 1Y (TTM)103.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)-11.47%
Revenue growth 3Y-11.31%
Revenue growth 5Y-6%
Sales Q2Q%-19.14%
3.2 Future
CFX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.59% yearly.
The Revenue is expected to decrease by -4.88% on average over the next years.
EPS Next Y-140.85%
EPS Next 2Y-46.61%
EPS Next 3Y29.17%
EPS Next 5Y47.59%
Revenue Next Year-15.23%
Revenue Next 2Y-8.73%
Revenue Next 3Y-4.88%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.33, which indicates a rather expensive current valuation of CFX.
83.33% of the companies in the same industry are more expensive than CFX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CFX to the average of the S&P500 Index (27.02), we can say CFX is valued slightly cheaper.
The Forward Price/Earnings Ratio is negative for CFX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.33 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CFX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CFX is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CFX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.42 | ||
| EV/EBITDA | 0.65 |
4.3 Compensation for Growth
CFX's earnings are expected to grow with 29.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.61%
EPS Next 3Y29.17%
5. Dividend
5.1 Amount
CFX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CFX (9/8/2025, 7:00:00 PM)
0.55
-0.01 (-1.79%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)
Earnings (Next)
Inst Owners19.91%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap35.88M
Analysts72.5
Price Target1.03 (87.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-51.38%
Min EPS beat(2)-89%
Max EPS beat(2)-13.76%
EPS beat(4)2
Avg EPS beat(4)25.64%
Min EPS beat(4)-89%
Max EPS beat(4)138.33%
EPS beat(8)5
Avg EPS beat(8)29.75%
EPS beat(12)6
Avg EPS beat(12)-72.2%
EPS beat(16)7
Avg EPS beat(16)-84.6%
Revenue beat(2)1
Avg Revenue beat(2)1.94%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)4.48%
Revenue beat(4)2
Avg Revenue beat(4)-2.72%
Min Revenue beat(4)-15.23%
Max Revenue beat(4)4.48%
Revenue beat(8)4
Avg Revenue beat(8)-1.67%
Revenue beat(12)6
Avg Revenue beat(12)-0.66%
Revenue beat(16)9
Avg Revenue beat(16)0.24%
PT rev (1m)-15.83%
PT rev (3m)-15.83%
EPS NQ rev (1m)-26.92%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-214.81%
EPS NY rev (3m)-214.81%
Revenue NQ rev (1m)-3.75%
Revenue NQ rev (3m)-7.77%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-2.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.33 | ||
| Fwd PE | N/A | ||
| P/S | 0.05 | ||
| P/FCF | 2.42 | ||
| P/OCF | 0.67 | ||
| P/B | 0.2 | ||
| P/tB | 0.2 | ||
| EV/EBITDA | 0.65 |
EPS(TTM)0.03
EY5.45%
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)0.23
FCFY41.25%
OCF(TTM)0.82
OCFY148.57%
SpS11.2
BVpS2.71
TBVpS2.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -35.35% | ||
| ROE | -87.05% | ||
| ROCE | 5.07% | ||
| ROIC | 2.73% | ||
| ROICexc | 2.74% | ||
| ROICexgc | 2.74% | ||
| OM | 1.55% | ||
| PM (TTM) | N/A | ||
| GM | 22.02% | ||
| FCFM | 2.03% |
ROA(3y)-20.14%
ROA(5y)-13.63%
ROE(3y)-46.33%
ROE(5y)-30.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.78%
GM growth 5Y-0.73%
F-Score5
Asset Turnover1.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 5.18 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 86.32% | ||
| Cap/Sales | 5.27% | ||
| Interest Coverage | 1.06 | ||
| Cash Conversion | 95.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.23 | ||
| Altman-Z | 0.85 |
F-Score5
WACC9.77%
ROIC/WACC0.28
Cap/Depr(3y)90.9%
Cap/Depr(5y)90.41%
Cap/Sales(3y)7.88%
Cap/Sales(5y)7.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y-140.85%
EPS Next 2Y-46.61%
EPS Next 3Y29.17%
EPS Next 5Y47.59%
Revenue 1Y (TTM)-11.47%
Revenue growth 3Y-11.31%
Revenue growth 5Y-6%
Sales Q2Q%-19.14%
Revenue Next Year-15.23%
Revenue Next 2Y-8.73%
Revenue Next 3Y-4.88%
Revenue Next 5YN/A
EBIT growth 1Y114.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.96%
EBIT Next 3Y38.37%
EBIT Next 5Y25.98%
FCF growth 1Y260.98%
FCF growth 3Y-52.34%
FCF growth 5YN/A
OCF growth 1Y-35.71%
OCF growth 3Y-26.8%
OCF growth 5Y-0.34%